Metropolis Healthcare

What Metropolis Healthcare does

Metropolis Healthcare Limited is India's second-largest pathology laboratory chain, founded in 1980 by Dr. Sushil Shah and headquartered in Mumbai. The company operates 170+ advanced clinical laboratories and 5,000+ patient service centres across 220+ cities and 750+ towns in India, with international operations spanning Ghana, Kenya, Zambia, Mauritius, Tanzania, and Sri Lanka. It serves individual patients, hospitals, corporate clients, and pharmaceutical/clinical research organizations through both B2C walk-in and home-visit channels and B2B lab outsourcing arrangements.

The company's core platform comprises a 4,000+ test menu spanning routine, semi-specialty, and super-specialty diagnostics across oncology, neurology, nephrology, gynecology, and reproductive genomics. Technical infrastructure includes an 8-state MET Protocol for sample processing, dual NABL and CAP accreditation, the recently launched Centre of Genomics powered by Illumina NovaSeq X Series sequencing, and AI algorithms deployed across the diagnostic ecosystem. Supporting products include the TruHealth preventive health package portfolio (Basic through Elite tiers), TruHealth Cancer Screen 360, and GLP-1 monitoring packages for weight management patients, complemented by the TruHealth mobile application and digital report delivery via email, WhatsApp, and online portal.

Metropolis generates revenue primarily through transactional per-test fees paid by individual patients (B2C) and managed services contracts with hospitals and corporate wellness clients (B2B). In Q4 FY26, B2C revenue reached Rs 251 crore (20% YoY growth) and B2B revenue Rs 174 crore (28% YoY growth), with FY26 consolidated revenue of Rs 1,645.84 crore and net profit of Rs 190.01 crore. Pricing ranges from Rs 90 for basic tests to Rs 18,500+ for specialized panels, with preventive packages priced Rs 1,000-11,000. The company is publicly listed on the NSE/BSE under the symbol METROPOLIS and has pursued an active M&A strategy, completing four acquisitions in the trailing 12 months including Core Diagnostics (December 2025) to expand specialty and genomics capabilities.

Name

Metropolis Healthcare

Legal name

Metropolis Healthcare Limited

Website

https://metropolisindia.com

Company type

Public

Founded year

1980

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Metropolis Healthcare is India's second-largest pathology laboratory chain, operating 5,000+ patient service centres and 170+ advanced labs across 750+ towns. It serves individual patients, hospitals, corporates, and pharma clients with 4,000+ diagnostic tests including genomics, preventive health packages, and specialty diagnostics.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)

akta.pro secondary industries

Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF), Clinical Specimen & Lab Diagnostics Courier (Blood, Tissue, Pathology) (TLAAAIAA)

Keywords

• Diagnostic testing services
• Pathology laboratory services
• Preventive health checkups
• Genomic testing services
• Clinical trial support

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. B2C Diagnostic Testing: Direct patient testing services through owned and franchised collection centres. Patients book tests online or visit centres directly. Revenue from individual test fees and health packages.
2. B2B Hospital and Corporate Partnerships: Laboratory outsourcing services for hospitals and corporate wellness programs. Includes hospital laboratory management and esoteric testing services for referring hospitals.
3. Clinical Trial Services: Analytical and support services for clinical research projects including site initiation, specimen logistics, analysis, reporting, and data management for contract research organizations.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels7 records

Core offering

Metropolis Healthcare operates a pan-India diagnostic and pathology laboratory chain offering 4000+ clinical tests across routine, semi-specialty, and super-specialty domains. It delivers services directly to consumers through owned and franchised patient service centres, home sample collection, and the TruHealth preventive health package portfolio, while also serving hospitals via laboratory outsourcing and esoteric testing referrals. The company is expanding into advanced genomics, molecular diagnostics, and AI-enabled precision medicine through its Centre of Genomics.

Product overview

Metropolis Healthcare operates a unified diagnostic services platform offering preventive health checkups, specialized diagnostic testing, and laboratory solutions. The core product portfolio includes TruHealth Packages (spanning Basic through Elite tiers), TruHealth Cancer Screen 360 for preventive oncology, GLP-1 monitoring packages for weight management patients, and the Centre of Genomics for precision medicine. Supporting services include home sample collection, hospital laboratory outsourcing, clinical trial support, and corporate wellness programs. The company offers 4000+ clinical laboratory tests across routine, semi-specialty and super-specialty domains including oncology, neurology, gynaecology, and nephrology.

Differentiator

Problem solved

Functional benefit

Brands

• TruHealth: Comprehensive health checkup packages including Mind & Body, Vital, Active, Proactive, Expert, and Elite tiers, as well as GLP-1 monitoring packages for weight management

Products and services

• TruHealth Health Checkup Packages Tiered preventive health checkup packages spanning Basic, Essential, Vital, Vital Plus, Active, Proactive, Expert, and Elite tiers designed for early detection and diagnostic screening. Includes 96-101 parameters across multiple profiles with optional Body Vitals Check and Tru Diet add-ons. Targets individual consumers seeking comprehensive preventive health assessments.
• TruHealth Cancer Screen 360 Comprehensive preventive oncology screening panel for early cancer detection, available in male and female versions. Targets the gap in early cancer detection across urban and rural populations in India.
• TruHealth GLP-1 Monitoring Packages Specialized monitoring test packages including GLP-1 Monitor, GLP-1 Ready, and GLP-1 Monitor Subscription targeting patients using GLP-1 receptor agonists for diabetes and weight management, enabling long-term tracking of individual responses and safety over time.
• Centre of Genomics Advanced genomics centre consolidating capabilities in precision medicine, molecular diagnostics, and genomic research. Operates CAP-accredited national referral laboratories powered by Illumina's NovaSeq X Series sequencing infrastructure with multidisciplinary teams of molecular pathologists, genomic scientists, bioinformaticians, and certified genetic counsellors. Supports 220+ validated assays.
• Individual Diagnostic Tests Comprehensive range of 4000+ clinical laboratory tests and profiles for prediction, early detection, diagnostic screening, confirmation and monitoring of diseases across routine, semi-specialty and super-specialty domains including Oncology, Neurology, Nephrology, and Gynecology.
• Home Sample Collection Service At-home blood sample collection service with trained phlebotomists visiting patients at preferred times with strict safety and hygiene protocols. Booking available via phone (080-4891-1400), mobile app, or website.
• Hospital Laboratory Solutions Full-scale in-house pathology services and solutions for partner hospitals, including outsourcing of esoteric testing and laboratory management for leading hospitals in India, Sri Lanka, and Africa.
• Clinical Trial Services Analytical and support services for clinical research projects including site initiation, specimen logistics, analysis, reporting, long-term specimen storage, data management, EDI and coordination for contract research organizations.
• Corporate Wellness Programs Pre-employment check-ups, employee health plans, and annual check-ups for corporates, including personalized Executive Health Check-up Programs targeting HR and administration teams.

Quantifiable outcome

• 5000+ diagnostic centres milestone achieved in FY26
• +6 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

One partnership is on record.

• Ivory (Brain Health Startup)minorStrategic or Co-development Partner · 15 April 2026Metropolis Healthcare partnered with Ivory, an AI-powered cognitive screening platform startup, to integrate brain health assessments into preventive health packages. The partnership allows Metropolis to offer cognitive screening services measuring attention, memory, and executive function as part of its comprehensive wellness offerings. Ivory has raised $1 million in funding from Draper Associates and SAGE Venture Fund.

Scale indicators24 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• SRL Diagnostics (Agilus Diagnostics): Operates one of India's largest diagnostic networks with comparable NABL/CAP-accredited labs and a strong hospital B2B outsourcing franchise. Backed by Fortis and later Manipal, it competes head-on in hospital lab management and esoteric testing.
• Thyrocare Technologies: Direct competitor in preventive and routine diagnostics, operating an asset-light central-lab model that competes on price. Now owned by PharmEasy/Tata 1mg group, it adds digital consumer reach and aggressive B2C pricing pressure that Metropolis must match.
• Dr. Lal PathLabs: India's largest diagnostic chain by revenue and a direct competitor across B2C pathology, preventive health packages, hospital B2B outsourcing, and home collection. Operates a similarly NABL/CAP-accredited hub-and-spoke model with a comparable test menu and geographic focus on North India.

Broad incumbents

• Apollo Diagnostics: Part of Apollo Hospitals Group, leveraging hospital network integration for B2B referrals and consumer brand trust. Operates a wide diagnostic menu and home collection but is broader in scope (parent is a hospital chain), making it a wider-portfolio incumbent rather than pure-play specialist.
• Quest Diagnostics: US-listed clinical laboratory giant operating a national reference-lab network and advanced diagnostics (including genomics and esoteric testing). Comparable in service breadth, NABL/CAP-equivalent accreditation footprint, and B2B hospital/health-plan contract orientation.
• Synlab Group: Europe's largest medical diagnostics services provider with global reference-lab capabilities. Comparable in scale, accreditation profile, and clinical-trial support services, and serves as a relevant international benchmark for Metropolis's globalisation and specialty ambitions.

Emerging players

• Strand Life Sciences: India-based genomics and precision medicine company now owned by Reliance. Directly comparable to Metropolis's Centre of Genomics in oncology genomics, reproductive diagnostics, and clinical research support, and a potential competitor for pharma-sponsored genomic programs.
• Neuberg Diagnostics: Fast-growing South-India-headquartered diagnostics chain expanding into genomics and integrated diagnostics. Competes with Metropolis in specialty and genomic testing and in hospital outsourcing partnerships, but at a smaller scale and more regional footprint.
• Tata 1mg Labs (Tata 1mg): Digital-first diagnostics and pharmacy platform with Thyrocare integration, offering online booking, home collection, and aggressive pricing. Competes in the same B2C funnel as Metropolis's TruHealth app and website channel.

Regional players

• Suburban Diagnostics: Strong West India (Mumbai/Pune) diagnostic chain with comparable NABL-accredited lab network and home collection services. Directly overlaps Metropolis's home market of Mumbai, making it a regional competitor for B2C volumes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MetropolisIndia
• YouTubeyoutube.com/user/MetropolisHealthcare
• Facebookfacebook.com/info
• LinkedInlinkedin.com/company/metropolis-india
• Instagraminstagram.com/metropolis_labs

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metropolis Healthcare